BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8329 related articles for article (PubMed ID: 30178033)

  • 1. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
    Tricco AC; Lillie E; Zarin W; O'Brien KK; Colquhoun H; Levac D; Moher D; Peters MDJ; Horsley T; Weeks L; Hempel S; Akl EA; Chang C; McGowan J; Stewart L; Hartling L; Aldcroft A; Wilson MG; Garritty C; Lewin S; Godfrey CM; Macdonald MT; Langlois EV; Soares-Weiser K; Moriarty J; Clifford T; Tunçalp Ö; Straus SE
    Ann Intern Med; 2018 Oct; 169(7):467-473. PubMed ID: 30178033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
    Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
    Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
    O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
    Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.
    Gates M; Gates A; Pieper D; Fernandes RM; Tricco AC; Moher D; Brennan SE; Li T; Pollock M; Lunny C; Sepúlveda D; McKenzie JE; Scott SD; Robinson KA; Matthias K; Bougioukas KI; Fusar-Poli P; Whiting P; Moss SJ; Hartling L
    BMJ; 2022 Aug; 378():e070849. PubMed ID: 35944924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
    Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.
    Wang X; Chen Y; Liu Y; Yao L; Estill J; Bian Z; Wu T; Shang H; Lee MS; Wei D; Tian J; Ma B; Wang Y; Tian G; Yang K
    BMC Complement Altern Med; 2019 Aug; 19(1):208. PubMed ID: 31405367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration.
    Zhang X; Tan R; Lam WC; Cheng CW; Yao L; Wang XQ; Li SY; Aixinjueluo QY; Yang KH; Shang HC; Wu TX; Lyu AP; Bian ZX
    Syst Rev; 2020 Oct; 9(1):247. PubMed ID: 33100229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    PLoS Med; 2009 Jul; 6(7):e1000100. PubMed ID: 19621070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRISMA harms checklist: improving harms reporting in systematic reviews.
    Zorzela L; Loke YK; Ioannidis JP; Golder S; Santaguida P; Altman DG; Moher D; Vohra S;
    BMJ; 2016 Feb; 352():i157. PubMed ID: 26830668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    Int J Equity Health; 2015 Oct; 14():92. PubMed ID: 26450828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research.
    Kapadia MZ; Askie L; Hartling L; Contopoulos-Ioannidis D; Bhutta ZA; Soll R; Moher D; Offringa M
    BMJ Open; 2016 Apr; 6(4):e010270. PubMed ID: 27091820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews.
    Rethlefsen ML; Kirtley S; Waffenschmidt S; Ayala AP; Moher D; Page MJ; Koffel JB;
    Syst Rev; 2021 Jan; 10(1):39. PubMed ID: 33499930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.
    Elsman EBM; Butcher NJ; Mokkink LB; Terwee CB; Tricco A; Gagnier JJ; Aiyegbusi OL; Barnett C; Smith M; Moher D; Offringa M
    Syst Rev; 2022 Jun; 11(1):121. PubMed ID: 35698213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process of pain assessment in people with dementia living in nursing homes: a scoping review protocol.
    Overen CK; Larsson M; Hillestad AH; Eriksen S
    BMJ Open; 2022 Sep; 12(9):e063230. PubMed ID: 36171025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 417.